San Diego, California — According to state and local economic development sources Aji Bio plans to invest $959,330.00 to build out 11,155 square feet of new space in San Diego. The company plans to occupy the new space at 3550 Dunhill St in San Diego, on or about January 1, 2022. According to the company website Ajinomoto Bio-Pharma Services is a fully integrated contract development and manufacturing organization with sites in Belgium, United States, Japan, and India providing comprehensive development, cGMP manufacturing, and aseptic fill finish services for small and large molecule APIs and intermediates. Ajinomoto Bio-Pharma Services offers a broad range of innovative platforms and capabilities for pre-clinical and pilot programs to commercial quantities, including: Corynex protein expression technology, oligonucleotide synthesis, antibody drug conjugations (ADC), high potency APIs (HPAPI), biocatalysis, continuous flow manufacturing and more. Ajinomoto Bio-Pharma Services is dedicated to providing a high level of quality and service to meet our clients needs.

To learn more about Aji Bio, visit http://ajibio-pharma.com/

Company Contact:
Nobuhisa Shimba, Chief Executive Officer
https://www.linkedin.com/in/nobuhisa-shimba-02152482/
858-882-0123

SOURCE: http://www.intelligence360.io
Copyright (c) 2021 SI360 Inc. All rights reserved